ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,561,000 | -5.3% | 237,155 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $2,704,000 | +25.2% | 237,155 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $2,160,000 | -38.9% | 237,155 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $3,538,000 | -42.0% | 237,155 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $6,095,000 | -1.5% | 237,155 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $6,185,000 | -26.2% | 237,155 | -0.1% | 0.01% | -33.3% |
Q1 2021 | $8,379,000 | -30.0% | 237,353 | -50.0% | 0.01% | +33.3% |
Q4 2020 | $11,972,000 | +33.9% | 474,310 | +100.0% | 0.01% | -43.8% |
Q3 2020 | $8,943,000 | -11.9% | 237,155 | 0.0% | 0.02% | -23.8% |
Q2 2020 | $10,155,000 | +120.3% | 237,155 | 0.0% | 0.02% | +90.9% |
Q1 2020 | $4,610,000 | – | 237,155 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |